Additionally, studies involving ALS mouse models showed that either the passive transfer of endogenous Tregs18 or intraperitoneal injection of rapamycin and IL-2c (IL-2 together with its monoclonal antibody)16 can efficiently expand the Treg count and prolong survival. This evidence concerns the gene IL2 and amyotrophic lateral sclerosis.